Hypertension is a highly prevalent risk factor for stroke and dementia, and is the greatest risk factor for small-vessel disease—a frequent cause of lacunar infarction and intracerebral haemorrhage. Lacunar and cortical strokes contribute to the development of dementia in patients with, and in those without, Alzheimer disease pathology; this relationship between stroke and dementia is probably mediated by ischaemia-induced neuroinflammation. Antihypertensive treatment can reduce the risk of stroke and dementia, but requires optimal blood pressure targets to be established for individual patients. Although the rate of treatment and control of hypertension has improved markedly over the past two decades, many physicians remain reluctant to prescribe antihypertensive medication to elderly patients owing to potential adverse events such as cardiovascular morbidity and postural hypotension. In this article we argue that, in patients of all ages, not treating hypertension is a missed opportunity to prevent some of the most prevalent brain diseases.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Lawes, C. M., Vander Hoorn, S. & Rodgers, A. Global burden of blood-pressure-related disease, 2001. Lancet 371, 1513–1518 (2008).
Lewington, S. et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903–1913 (2002).
Li, C., Engström, G., Hedblad, B., Berglund, G. & Janzon, L. Risk factors for stroke in subjects with normal blood pressure: a prospective cohort study. Stroke 36, 234–238 (2005).
Spence, J. D. Antihypertensive drugs and prevention of atherosclerotic stroke. Stroke 17, 808–810 (1986).
Roger, V. L. et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation 125, e2–e220 (2012).
Birns, J. & Kalra, L. Cognitive function and hypertension. J. Hum. Hypertens. 23, 86–96 (2009).
Schiller, J. S., Lucas, J. W., Ward, B. W. & Peregoy, J. A. Summary health statistics for U.S. adults: National Health Interview Survey, 2010. Vital Health Stat. 10, 1–207 (2012).
Pantoni, L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 9, 689–701 (2010).
Hachinski, V. & Norris, J. W. The Acute Stroke 1–286 (F. A. Davis, Philadelphia, 1985).
O'Rourke, M. F. & Safar, M. E. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 46, 200–204 (2005).
Labovitz, D. L., Halim, A., Boden-Albala, B., Hauser, W. A. & Sacco, R. L. The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology 65, 518–522 (2005).
Vermeer, S. E. et al. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 34, 392–396 (2003).
Das, R. R. et al. Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke 39, 2929–2935 (2008).
Spence, J. D. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol. 6, 830–838 (2007).
Poli, D. et al. Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine. Stroke 36, 2159–2163 (2005).
Böger, R. H., Bode-Böger, S. M., Sydow, K., Heistad, D. D. & Lentz, S. R. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 20, 1557–1564 (2000).
Snowdon, D. A. et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813–817 (1997).
Skoog, I., Andreasson, L. A., Landahl, S. & Lernfelt, B. A population-based study on blood pressure and brain atrophy in 85-year-olds. Hypertension 32, 404–409 (1998).
Peters, R. et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 7, 683–689 (2008).
Oveisgharan, S. & Hachinski, V. Hypertension, executive dysfunction, and progression to dementia: the Canadian study of health and aging. Arch. Neurol. 67, 187–192 (2010).
Whitehead, S. N., Cheng, G., Hachinski, V. C. & Cechetto, D. F. Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid. Stroke 38, 3245–3250 (2007).
Whitehead, S. N., Hachinski, V. C. & Cechetto, D. F. Interaction between a rat model of cerebral ischemia and β-amyloid toxicity: inflammatory responses. Stroke 36, 107–112 (2005).
Whitehead, S., Cheng, G., Hachinski, V. & Cechetto, D. F. Interaction between a rat model of cerebral ischemia and β-amyloid toxicity: II. Effects of triflusal. Stroke 36, 1782–1789 (2005).
Whitehead, S. N. et al. Triflusal reduces cerebral ischemia induced inflammation in a combined mouse model of Alzheimer's disease and stroke. Brain Res. 1366, 246–256 (2010).
Musini, V. M., Tejani, A. M., Bassett, K. & Wright, J. M. Pharmacotherapy for hypertension in the elderly. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD000028. http://dx.doi.org/10.1002/14651858.CD000028.pub2.
Beckett, N. S. et al. Treatment of hypertension in patients 80 years of age or older. N. Engl. J. Med. 358, 1887–1898 (2008).
Lewington, S., Clarke, R., Qizilbash, N., Peto, R. & Collins, R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903–1913 (2002).
Rothwell, P. M., Howard, S. C. & Spence, J. D. Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 34, 2583–2590 (2003).
Lee, M., Saver, J. L., Hong, K. S., Hao, Q. & Ovbiagele, B. Does achieving an intensive versus usual blood pressure level prevent stroke? Ann. Neurol. 71, 133–140 (2012).
McGuinness, B., Todd, S., Passmore, P. & Bullock, R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD004034. http://dx.doi.org/10.1002/14651858.CD004034.pub3.
Pendlebury, S. T., Cuthbertson, F. C., Welch, S. J., Mehta, Z. & Rothwell, P. M. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 41, 1290–1293 (2010).
Hachinski, V. et al. National Institute of Neurological Disorders and Stroke—Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37, 2220–2241 (2006).
Forette, F. et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch. Intern. Med. 162, 2046–2052 (2002).
Spence, J. D., Sibbald, W. J. & Cape, R. D. Pseudohypertension in the elderly. Clin. Sci. Mol. Med. Suppl. 4, 399s–402s (1978).
Spence, J. D., Sibbald, W. J. & Cape, R. D. Direct, indirect and mean blood pressures in hypertensive patients: the problem of cuff artefact due to arterial wall stiffness, and a partial solution. Clin. Invest. Med. 2, 165–173 (1979).
Spence, J. D. Pseudohypertension. Hypertension 59, e49 (2012).
Stewart, R. et al. Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension 54, 233–240 (2009).
Royall, D. R., Gao, J. H. & Kellogg, D. L. Jr. Insular Alzheimer's disease pathology as a cause of “age-related” autonomic dysfunction and mortality in the non-demented elderly. Med. Hypotheses 67, 747–758 (2006).
Sörös, P., Inamoto, Y. & Martin, R. E. Functional brain imaging of swallowing: an activation likelihood estimation meta-analysis. Hum. Brain Mapp. 30, 2426–2439 (2009).
Oppenheimer, S. M., Gelb, A., Girvin, J. P. & Hachinski, V. C. Cardiovascular effects of human insular cortex stimulation. Neurology 42, 1727–1732 (1992).
Sörös, P. & Hachinski, V. Cardiovascular and neurological causes of sudden death after ischaemic stroke. Lancet Neurol. 11, 179–188 (2012).
Braak, H. & Braak, E. Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural Transm. Suppl. 53, 127–140 (1998).
Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364, 937–952 (2004).
O'Donnell, M. J. et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case–control study. Lancet 376, 112–123 (2010).
The authors declare no competing financial interests.
About this article
Cite this article
Sörös, P., Whitehead, S., Spence, J. et al. Antihypertensive treatment can prevent stroke and cognitive decline. Nat Rev Neurol 9, 174–178 (2013). https://doi.org/10.1038/nrneurol.2012.255
Cerebral Circulation - Cognition and Behavior (2021)
The Neuroradiology Journal (2021)
BMJ Evidence-Based Medicine (2020)